Occlutech, a European developer of minimally invasive implants for heart disease, has received a favourable court ruling from Stockholm, Sweden in the on-going patent litigation with AGA Medical -St Jude Medical.
In the ruling by Stockholms tingsratt, the district court of Stockholm, the court does not see any basis for AGA-St Jude’s claim that the Occlutech ASD and PFO occluders violate any patent brought forward in the litigation.
The Stockholm rulings are similar to ruling in UK and The Netherlands, which are subject to appeal by AGA-St Jude Medical.
Throughout the litigation, Occlutech’s owners and investors have funded work in maintaining and strengthening Occlutech’s own patent position.